跳至主要内容
临床试验/NL-OMON37941
NL-OMON37941已完成不适用

Can memantine prevent memory impairment induced by MDMA in humans - MDMA and Memantine

niversiteit Maastricht0 个研究点目标入组 21 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
21

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Recreational MDMA users (used at least 3 times of which at least once during the previous year, and maximally 200 times)
  • Age between 18 and 40 years
  • Free from psychotropic medication
  • Good physical health as determined by medical examination and laboratory analysis
  • Absence of any major medical, endocrine and neurological condition
  • Normal weight, body mass index (weight/height2) between 18.5 and 28 kg/m2
  • Written Informed Consent

排除标准

  • History of drug abuse (other than the use of MDMA) or addiction
  • Pregnancy or lactation
  • Excessive drinking (> 20 alcoholic consumptions a week)
  • Hypertension (diastolic> 90; systolic> 140)
  • Current or history of psychiatric disorder
  • Liver dysfunctioning
  • (Serious) side effects to previous MDMA use
  • History of cardiac dysfunctions (arrhythmia, ischemic heart disease,*)
  • For women: no use of a reliable contraceptive

研究者

相似试验